✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals
Market Cap
₹26,055 Cr.
P/E
33.94
  • Pfizer
  • Wockhardt
  • JB Chem & Pharma
  • TJI Pharma
FAQs on Pfizer Ltd. Shareprice

Pfizer has given lower returns compared to its competitors.
Pfizer has grown at ~0.53% over the last 4yrs while peers have grown at a median rate of 21.78%

Pfizer is expensive when considering the EV/EBIDTA, however latest PE is < 3 yr avg PE.
Latest PE of Pfizer is 33.94, while 3 year average PE is 37.06.
Also latest EV/EBITDA of Pfizer is 31.42 while 3yr average is 26.23.

Growth Table
  • Pfizer Ltd.
  • Wockhardt
  • JB Chem & Pharma
Balance Sheet
  • Pfizer Ltd.
  • Wockhardt
  • JB Chem & Pharma
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Pfizer Ltd.
  • Wockhardt
  • JB Chem & Pharma
Cash Flow
  • Pfizer Ltd.
  • Wockhardt
  • JB Chem & Pharma
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Pfizer Ltd.
  • Wockhardt
  • JB Chem & Pharma
Quarterly Results
  • Pfizer Ltd.
  • Wockhardt
  • JB Chem & Pharma
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
FAQs on Pfizer Ltd. Financials

Balance sheet of Pfizer is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Pfizer is increasing.
Latest net debt of Pfizer is -₹2,798.48 Crs as of Mar-25.
This is greater than Mar-24 when it was -₹4,085.28 Crs.

The profit is oscillating.
The profit of Pfizer is ₹768 Crs for TTM, ₹551 Crs for Mar 2024 and ₹624 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Pfizer latest dividend payout ratio is 29.04% and 3yr average dividend payout ratio is 34.26%

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments

Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech